このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Showing Health Information Value in a Community Network

2014年7月9日 更新者:Duke University
The purpose of this study is to determine the value of shared health information on care quality and costs when this information is used to notify care providers about concerning health events for patients cared for by a community-based network of providers.

調査の概要

詳細な説明

Project Abstract This three-year project will assess the costs and benefits of health information technology (HIT) in an established community-wide network of academic, private and public healthcare facilities created to share clinical information for the purpose of population-based care management of over 16,000 Medicaid beneficiaries in Durham County, North Carolina. The area of interest for this project is the impact of information-driven interventions on care quality, patient safety and healthcare costs across the diverse stakeholders participating in this collaborative partnership. In order to asses HIT value rigorously in the context of a production information system that is under continual development, we propose to conduct a randomized controlled trial. Specifically, we will randomly assign patients by family unit to either a control group or to an intervention group in which they will initially receive one of 3 information-driven interventions. The interventions include clinical alerts sent to care providers, performance feedback reports presented to clinic managers, and care reminders sent directly to patients. The content of the interventions will address "concerning" events (e.g., an emergency room encounter for asthma) and care deficiencies (e.g., delinquency on biannual mammogram) identified from the composite set of clinical data in our information system. To assess the benefits and burdens of the interventions, combinations of the 3 interventions will be sequentially introduced into the study groups over the course of the project. The analysis will compare groups receiving various combinations of interventions as well as those receiving no interventions. At baseline and at six-month intervals throughout the course of the study, we will measure emergency department encounter rates, hospitalization rates, HEDIS (Healthcare Effectiveness Data and Information Set) scores, missed appointment rates, glycated hemoglobin levels in diabetics, and patient satisfaction. Our assessment will look at the societal value of HIT as well as the value for individual stakeholders including patients, providers, payers, purchasers and policy makers. From these measures, we will assess the costs and benefits of this community-wide effort to promote interoperability of clinical data exchange in order to increase the understanding of HIT value in a community setting. In our preliminary studies, we have observed a statistically significant 3-fold reduction in repeat ED (Emergency Department) encounter rates using email alerts alone. The approach used in this project is able to be generalized across geographic areas and healthcare settings and can, therefore, serve to promote the dissemination of HIT to other communities.

研究の種類

介入

入学 (実際)

20108

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • North Carolina
      • Durham、North Carolina、アメリカ、27710
        • Duke University Medical Center

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Enrollment in the Community Care of North Carolina Medicaid program in Durham County North Carolina

Exclusion Criteria:

-

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:階乗代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:1
electronic mail notifications to care managers about sentinel health events
computer decision support system that generates notifications about sentinel health events and communicates this information via electronic mail to care managers, feedback reports to clinical managers, and letters to patients
他の名前:
  • Decision support engine is called SEBASTIAN
実験的:2
feedback reports with notifications to clinic managers about sentinel health events
computer decision support system that generates notifications about sentinel health events and communicates this information via electronic mail to care managers, feedback reports to clinical managers, and letters to patients
他の名前:
  • Decision support engine is called SEBASTIAN
実験的:3
letters to patients with notifications about sentinel health events
computer decision support system that generates notifications about sentinel health events and communicates this information via electronic mail to care managers, feedback reports to clinical managers, and letters to patients
他の名前:
  • Decision support engine is called SEBASTIAN
介入なし:4
electronic mail notifications to care managers about sentinel health events -- generated but withheld
介入なし:5
feedback reports with notifications to clinic managers about sentinel health events -- generated but withheld
介入なし:6
letters to patients with notifications about sentinel health events -- generated but withheld

この研究は何を測定していますか?

主要な結果の測定

結果測定
時間枠
Emergency department utilization rates and hospitalization rates
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.

二次結果の測定

結果測定
時間枠
ED encounter rates for low severity conditions
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
ED encounter rates for asthma
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
ED encounter rates for diabetes
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Hospitalization rates
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Hospitalization rates for asthma (also PQI)
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Hospitalization rates for diabetes (also PQI)
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Glycemic control (hemoglobin A1c)
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Medication contraindications
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
HEDIS - Preventive services
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
HEDIS - # WCC visits
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
AHRQ Prevention Quality Indicators
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
HEDIS - Asthma and diabetes
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
# of messages triggered for health risks
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
# of messages triggered for barriers to care
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Missed appointment rates
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Primary care appointment rates
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
F/U rates post-partum
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Patient satisfaction instruments (CHAPS)
時間枠:at 6 to 9 months after the intervention has been introduced and then at 3 to 6-month intervals as the intervention is sequentially enhanced.
at 6 to 9 months after the intervention has been introduced and then at 3 to 6-month intervals as the intervention is sequentially enhanced.
EuroQoL
時間枠:at 6 to 9 months after the intervention has been introduced and then at 3 to 6-month intervals as the intervention is sequentially enhanced.
at 6 to 9 months after the intervention has been introduced and then at 3 to 6-month intervals as the intervention is sequentially enhanced.
Provider opinion surveys
時間枠:At conclusion of study
At conclusion of study
Costs of ED utilization for all causes
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Costs of ED use for asthma
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Costs of ED use for diabetes
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Costs of ED use for low severity visits
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Hospitalization costs for all causes
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Hospitalization costs for asthma
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Hospitalization costs for diabetes
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Reimbursement for labs+other ancillary services
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
Primary care reimbursement
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
ED rates for recurrent ED encounters
時間枠:at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.
at 9 months after the intervention has been introduced and then at 6-month intervals as the intervention is sequentially enhanced.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:David F Lobach, MD, PhD、Duke University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2006年8月1日

一次修了 (実際)

2008年7月1日

研究の完了 (実際)

2008年8月1日

試験登録日

最初に提出

2006年8月16日

QC基準を満たした最初の提出物

2006年8月16日

最初の投稿 (見積もり)

2006年8月18日

学習記録の更新

投稿された最後の更新 (見積もり)

2014年7月11日

QC基準を満たした最後の更新が送信されました

2014年7月9日

最終確認日

2012年12月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • Pro00006833
  • R01HS015057 (米国 AHRQ グラント/契約)

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する